PMID: 9193886Jun 1, 1997Paper

The effects of hormone replacement therapy on coronary heart disease

Endocrinology and Metabolism Clinics of North America
M M Sotelo, S R Johnson

Abstract

The importance of cardiovascular disease as a cause of morbidity and mortality in women is well appreciated. Cardiovascular disease accounts for approximately 48% of deaths in women in the United States. In particular, coronary heart disease (CHD) accounts for approximately one-half of these deaths. This article describes current evidence that suggests it is premature to recommend hormone replacement therapy (HRT) as a proven prevention strategy for CHD.

References

Oct 1, 1976·Annals of Internal Medicine·W B KannelT Gordon
Dec 4, 1975·The New England Journal of Medicine·D C SmithW L Herrmann
Oct 1, 1992·British Journal of Obstetrics and Gynaecology·M FalkebornT Naessén
Dec 15, 1992·Annals of Internal Medicine·D GradyS R Cummings
Sep 15, 1991·Annals of Internal Medicine·E Barrett-Connor
Jul 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·E Barrett-Connor, M Laakso
Nov 1, 1990·American Journal of Obstetrics and Gynecology·J A CauleyD G Seeley
Dec 1, 1990·Archives of Internal Medicine·J M SullivanD M Mirvis
Oct 1, 1990·American Journal of Public Health·R B HarrisW L Haskell
Jun 1, 1989·Journal of Epidemiology and Community Health·S G ThompsonG Greenberg
Nov 1, 1995·Progress in Cardiovascular Diseases·T B ClarksonK P Klein
Nov 1, 1995·Progress in Cardiovascular Diseases·F Grodstein, M Stampfer
Nov 1, 1995·Progress in Cardiovascular Diseases·J M Sullivan
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·C P WeinerS Moncada
Oct 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·V SalomaaG Myllylä
Nov 15, 1995·Journal of the American College of Cardiology·S A Samaan, M H Crawford
May 1, 1995·Epidemiology·S R SturgeonR N Hoover
Aug 1, 1995·American Journal of Obstetrics and Gynecology·C A DerbyR A Carleton
Dec 15, 1994·Annals of Internal Medicine·E H LiebermanM A Creager
Oct 11, 1993·Archives of Internal Medicine·S M VaziriP W Wilson
Jan 1, 1996·Obstetrics and Gynecology·B EttingerC P Quesenberry
Feb 1, 1996·Obstetrics and Gynecology·R A Wild
May 2, 1996·The New England Journal of Medicine·G S OmennS Hammar
May 15, 1996·American Journal of Epidemiology·K A MatthewsP Plantinga

❮ Previous
Next ❯

Citations

Sep 25, 1999·Thrombosis Research·H H Vorster
Apr 23, 2003·Cardiology in Review·Jesse WeinbergerDawn Terashita
Jun 13, 2002·Clinical Chemistry and Laboratory Medicine : CCLM·Aldo ClericoDaniela Giannessi
Jun 19, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Michele EmdinAldo Clerico
Dec 10, 2008·Endothelium : Journal of Endothelial Cell Research·Maria FlorianSheldon Magder
Jun 1, 2001·Acta Clinica Belgica·B Velkeniers
Oct 22, 2005·Endocrine Research·Sing-Kai ChuoDe Chang Shen
Oct 16, 1999·Annals of Internal Medicine·S E McNagny
Jan 29, 2000·The American Journal of Clinical Nutrition·J M Gill, A E Hardman

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.